you are here:

Ipca Laboratories Ltd.

BSE: 524494 | NSE: IPCALAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE571A01020 | SECTOR: Pharmaceuticals

BSE Live

Feb 26, 14:28
1850.00 -15.50 (-0.83%)
Volume
AVERAGE VOLUME
5-Day
15,371
10-Day
13,504
30-Day
14,487
7,868
  • Prev. Close

    1865.50

  • Open Price

    1874.95

  • Bid Price (Qty.)

    1848.10 (6)

  • Offer Price (Qty.)

    1852.80 (21)

NSE Live

Feb 26, 14:28
1851.15 -15.65 (-0.84%)
Volume
AVERAGE VOLUME
5-Day
225,799
10-Day
214,852
30-Day
280,115
213,092
  • Prev. Close

    1866.80

  • Open Price

    1851.20

  • Bid Price (Qty.)

    1848.95 (7)

  • Offer Price (Qty.)

    1851.95 (21)

Financials

2020 2019 2018 2017 2016
Half Yearly Results of Ipca Laboratories (in Rs. Cr.) Mar '20 Sep '19 Mar '19 Sep '18 Mar '18  
Net Sales/Income from operations 2,143.86 2,223.57 1,781.40 1,851.75 1,641.96  
Other Operating Income -- -- -- -- --  
Total Income From Operations 2,143.86 2,223.57 1,781.40 1,851.75 1,641.96  
EXPENDITURE  
Consumption of Raw Materials 721.69 709.41 560.32 537.70 450.87  
Purchase of Traded Goods 104.83 99.82 84.84 83.03 96.53  
Increase/Decrease in Stocks -118.05 -37.00 -76.48 -29.66 2.44  
Power & Fuel -- -- -- -- --  
Employees Cost 445.60 425.19 353.07 399.17 350.91  
Depreciation 91.54 87.15 84.23 87.65 86.97  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 531.63 569.55 453.28 574.71 470.12  
P/L Before Other 366.62 369.45 322.14 199.15 184.12  
Other Income 30.93 33.76 27.21 27.38 22.36  
P/L Before Int. 397.55 403.21 349.35 226.53 206.48  
Interest 7.27 8.52 11.18 7.31 12.05  
P/L Before Exceptional Items & Tax 390.28 394.69 338.17 219.22 194.43  
Exceptional Items -- -- -- -- --  
P/L Before Tax 390.28 394.69 338.17 219.22 194.43  
Tax 65.89 66.62 68.52 33.96 37.54  
P/L After Tax from Ordinary Activities 324.39 328.07 269.65 185.26 156.89  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 324.39 328.07 269.65 185.26 156.89  
Equity Share Capital 25.27 25.27 25.27 25.27 25.24  
Reserves Excluding Revaluation Reserves -- 3,389.63 -- 2,847.82 --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 25.67 25.96 -- 14.66 --  
Diluted EPS -- 25.96 -- 14.66 --  
EPS After Extra Ordinary  
Basic EPS. 25.67 25.96 -- 14.66 --  
Diluted EPS. -- 25.96 -- 14.66 --  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited